Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2025-01-03T14:11:00.212Z Has data issue: false hasContentIssue false
  • English
  • Français

TOP TEN RESEARCH PRIORITIES FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER TREATMENT

Part of: Special Collection - Methods

Published online by Cambridge University Press:  12 August 2016

Stella Jacobson Open the ORCID record for Stella Jacobson [Opens in a new window] ,
Pernilla Östlund ,
Lena Wallgren ,
Marie Österberg  and
Sofia Tranæus
Stella Jacobson
Affiliation:
Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)[email protected]
Pernilla Östlund
Affiliation:
Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)Faculty of Odontology, Malmö University
Lena Wallgren
Affiliation:
Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)
Marie Österberg
Affiliation:
Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)
Sofia Tranæus
Affiliation:
Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)Faculty of Odontology, Malmö University, Department of Dental Medicine, Karolinska Institutet
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: The aim of this project was to identify the ten most important research questions for attention deficit/hyperactivity disorder (ADHD) treatment as identified by people with ADHD together with personnel involved in the treatment of ADHD in school, health, and correction services.

Methods: A working group consisting of consumers and personnel was established. The method for prioritization was primarily based on James Lind Alliance's guidebook, consisting of an interim priority setting exercise and a workshop.

Results: The top ten list includes the risk of drug dependency later in life when treated with methylphenidate as a child, teacher support, multimodal therapy, comparisons between atomoxetine and methylphenidate, methylphenidate treatment in substance abusers, parental support programmes, supported conversation, computer-aided working memory training, psychoeducative treatment, and melatonin.

Conclusions: We have shown that consumers and personnel can reach consensus on research priorities for treatments for ADHD. We encourage researchers and funders to consider the list for future studies.

Keywords

Mental disordersAttention deficit disorder with hyperactivityPatient participation
Type
Methods
Information
International Journal of Technology Assessment in Health Care , Volume 32 , Issue 3 , 2016 , pp. 152 - 159
Copyright
Copyright © Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. UK Database of Uncertainties about the Effects of Treatments (DUETs) [Internet]. National Institute for Health and Care Excellence (NICE). http://www.library.nhs.uk/duets/ (accessed May 2015).Google Scholar
2. Altman, DG. The scandal of poor medical research. BMJ. 1994;308:283-284.CrossRefGoogle ScholarPubMed
3. Chalmers, I, Glasziou, P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374:86-89.CrossRefGoogle ScholarPubMed
4. Tallon, D, Chard, J, Dieppe, P. Relation between agendas of the research community and the research consumer. Lancet. 2000;355:2037-2040.CrossRefGoogle ScholarPubMed
5. Lloyd, K, White, J. Democratizing clinical research. Nature. 2011;474:277-278.Google Scholar
6. James Lind Alliance (JLA). Southampton: National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre (NETSCC). James Lind Alliance. http://www.lindalliance.org/ (accessed May 2015).Google Scholar
7. Cowan, K. The James Lind alliance: Tackling treatment uncertainties together. J Ambul Care Manage. 2010;33:241-248.Google Scholar
8. The James Lind Alliance Guidebook. Southampton: James Lind Alliance. http://www.jlaguidebook.org/ (accessed May 2015).Google Scholar
9. SBU. ADHD - diagnostik och behandling, vårdens organisation och patientens delaktighet. En systematisk litteraturöversikt. Stockholm: Statens beredning för medicinsk utvärdering (SBU); SBU-rapport nr 217. 2013. ISBN 91-85413-58-4. English summary: http://www.sbu.se/en/Published/Yellow/Diagnostics-and-treatment-of-ADHD-and-ASDs-autism-spectrum-disorders-/ (accessed May, 2015).Google Scholar
10. Gaynes, BN, Christian, R, Saavedra, LM, et al. Attention-deficit/hyperactivity disorder: Identifying high priority future research needs. J Psychiatr Pract. 2014;20:104-117.Google Scholar
11. Treatment uncertainties [Internet]. Stockholm: Swedish council on health technology assessment (SBU). http://www.sbu.se/en/Published/Search-treatment-uncertainties/ (accessed May 2015).Google Scholar
12. Heintz, E, Lintamo, L, Hultcrantz, M, et al. Framework for systematic identification of ethical aspects of healthcare technologies: The SBU approach. Int J Technol Assess Health Care. 2015;31:124-130 CrossRefGoogle ScholarPubMed
13. Sundquist, J, Ohlsson, H, Sundquist, K, et al. Attention-deficit/hyperactivity disorder and risk for drug use disorder: A population-based follow-up and co-relative study. Psychol Med. 2015;45:977-983.Google Scholar